Compare Abeona Therapeutics Inc (ABEO) vs Marathon Digital Holdings Inc (MARA) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Marathon Digital Holdings Inc — how do they compare? Abeona Therapeutics Inc trades at $6.74 (market cap $373.32M), while Marathon Digital Holdings Inc trades at $11.76 (market cap $4.59B). The key difference: Marathon Digital Holdings Inc is far larger — about 12.3× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Marathon Digital Holdings Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | MARA | |
|---|---|---|
Market Cap | $373.32M | $4.59B |
Sector | Health | Technology |
52-Week High | $7.23 | $22.84 |
52-Week Low | $4.17 | $6.73 |
Enterprise Value | $228.22M | $6.54B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
MARA Holdings trades at $12.95, up 4.44% today, but faces significant fundamental challenges with a net income margin of -234.83% and three consecutive quarterly earnings misses. The technical picture remains bearish with key resistance at $13-$14, while analyst sentiment is mixed with a 50% buy rating but a consensus price target of $16.60. Recent developments include the shipment of a hybrid energy storage prototype system from TAE Power Solutions (PRNewsWire, June 30, 2026) and ongoing pivot toward AI infrastructure.
Despite the bullish analyst consensus and potential from AI infrastructure expansion, MARA faces substantial execution risks amid persistent losses and negative cash flow from operations. The stock's valuation appears attractive on P/E (3.37) and EV/EBITDA (3.31) metrics, but profitability concerns and Bitcoin market volatility create significant downside risk for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Marathon Digital Holdings Inc
Marathon Digital Holdings, Inc. is one of the largest publicly traded Bitcoin mining companies in North America. The company focuses on building and operating large-scale, cost-efficient Bitcoin mining facilities. Marathon's strategy centers on increasing its mining hash rate and using sustainable energy sources to expand its Bitcoin production. The company's performance is closely tied to the price of Bitcoin and the overall health of the digital asset mining industry.
Read more on MARA →
